This inventor holds 15 USPTO granted patents and 3 published patent applications and 3 EPO patents, primarily in Metabolic Disorder Treatment. Top assignees: Prosidion Limited, Pfizer Corporation, Warner-Lambert Company. Active years: 2003-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Birmingham, GB (2003 - 2007)
- Oxford, GB (2008 - 2012)
Company Filing History:
5 out of 16 
4 out of 4,489 
4 out of 2,538 
Years Active: 2003-2012
Areas of Expertise:
Sure, here is an article about inventor Stuart Edward Bradley:
Title: The Innovative Mind of Stuart Edward Bradley
Introduction:
Stuart Edward Bradley is a visionary inventor hailing from Birmingham, United Kingdom, with an impressive portfolio of 15 patents to his name. His groundbreaking work in the field of pharmaceuticals has led to significant advances in the treatment of metabolic disorders, paving the way for a healthier future.
Latest Patents:
1. Bicyclic Aryl and Heteroaryl Compounds for the Treatment of Metabolic Disorders: Stuart Edward Bradley's latest patent introduces compounds that act as opioid receptor modulators, offering promising solutions for the treatment of metabolic disorders, particularly obesity.
2. G-Protein Coupled Receptor Agonists: Another notable patent by Bradley features compounds that serve as agonists of GPR116, showcasing their potential in combating obesity and diabetes.
Career Highlights:
Bradley's career is marked by his invaluable contributions to renowned companies such as Prosidion Limited and Warner-Lambert Company. His innovative approach and unwavering dedication have solidified his reputation as a pioneer in the field of pharmaceutical research and development.
Collaborations:
Throughout his illustrious career, Stuart Edward Bradley has collaborated with esteemed professionals, including Martin James Procter and Eric W Collington. Together, they have spearheaded groundbreaking projects and pushed the boundaries of innovation in the pharmaceutical industry.
Conclusion:
In conclusion, Stuart Edward Bradley stands as a beacon of ingenuity and creativity in the realm of inventions and patents. His relentless pursuit of excellence and passion for driving positive change through his work continue to inspire and shape the landscape of pharmaceutical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile